000 | 01943 a2200505 4500 | ||
---|---|---|---|
005 | 20250515230953.0 | ||
264 | 0 | _c20110216 | |
008 | 201102s 0 0 eng d | ||
022 | _a1555-2101 | ||
024 | 7 |
_a10.4088/JCP.09m05031yel _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRitsner, Michael S | |
245 | 0 | 0 |
_aPregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial. _h[electronic resource] |
260 |
_bThe Journal of clinical psychiatry _cOct 2010 |
||
300 |
_a1351-62 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntipsychotic Agents _xadministration & dosage |
650 | 0 | 4 |
_aAttention _xdrug effects |
650 | 0 | 4 |
_aDehydroepiandrosterone _xadministration & dosage |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aDrug Therapy, Combination _xadverse effects |
650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMemory, Short-Term _xdrug effects |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeurotransmitter Agents _xadministration & dosage |
650 | 0 | 4 |
_aPregnenolone _xadministration & dosage |
650 | 0 | 4 |
_aPsychotic Disorders _xdrug therapy |
650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
650 | 0 | 4 | _aSeverity of Illness Index |
700 | 1 | _aGibel, Anatoly | |
700 | 1 | _aShleifer, Tatyana | |
700 | 1 | _aBoguslavsky, Igor | |
700 | 1 | _aZayed, Ahmad | |
700 | 1 | _aMaayan, Rachel | |
700 | 1 | _aWeizman, Abraham | |
700 | 1 | _aLerner, Vladimir | |
773 | 0 |
_tThe Journal of clinical psychiatry _gvol. 71 _gno. 10 _gp. 1351-62 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4088/JCP.09m05031yel _zAvailable from publisher's website |
999 |
_c19932020 _d19932020 |